Why was valsartan contaminated?
About This Video
The contamination of Valsartan was caused by manufacturing defects, with the active ingredient being manufactured overseas in China and India. This led to the introduction of NDMA and large quantities of MDMA into the medication, which was 200 times the threshold amount for daily intake. China’s role in the Valsartan litigation highlighted the issue of cutting corners to save money, ultimately resulting in the contamination of the medication.
Calling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch.com's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.